Clinical Trials Directory

Trials / Unknown

UnknownNCT02950207

Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100

Prospective Observational Study to Evaluate the Correlation Between Antitumor Activity of Hormone Therapy and the Expression of Micro-RNA (miRNA) 100

Status
Unknown
Phase
Study type
Observational
Enrollment
180 (estimated)
Sponsor
Fondazione del Piemonte per l'Oncologia · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Mono-centric, observational, prospective study, designed for pts with diagnosis of hormone-positive breast cancer to evaluate the correlation between the response to hormonal treatment indicated by the reduction of the level of Ki67 and miRNA100 in two groups of patients

Detailed description

The potential role of miRNAs will be studied as a predictor of hormone sensitivity in hormone-positive breast carcinomas. The miRNA100 obtained on biopsy will be compared with the expression levels of those obtained from the surgically removed tumor, in order to assess the possible modulation of miRNA100 following hormonal treatment.

Conditions

Interventions

TypeNameDescription
GENETICmiRNAmiRNA extraction

Timeline

Start date
2014-01-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2016-11-01
Last updated
2016-11-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02950207. Inclusion in this directory is not an endorsement.

Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100 (NCT02950207) · Clinical Trials Directory